Cite
mRNA-LNP vaccination-based immunotherapy augments CD8+ T cell responses against HPV-positive oropharyngeal cancer
MLA
Ke Qiu, et al. “MRNA-LNP Vaccination-Based Immunotherapy Augments CD8+ T Cell Responses against HPV-Positive Oropharyngeal Cancer.” Npj Vaccines, vol. 8, no. 1, Sept. 2023, pp. 1–15. EBSCOhost, https://doi.org/10.1038/s41541-023-00733-8.
APA
Ke Qiu, Xing Duan, Minzi Mao, Yao Song, Yufang Rao, Danni Cheng, Lan Feng, Xiuli Shao, Chuanhuan Jiang, Hai Huang, Yan Wang, Huifang Li, Xuemei Chen, Sisi Wu, Dan Luo, Fei Chen, Xingchen Peng, Yongbo Zheng, Haiyang Wang, … Jianjun Ren. (2023). mRNA-LNP vaccination-based immunotherapy augments CD8+ T cell responses against HPV-positive oropharyngeal cancer. Npj Vaccines, 8(1), 1–15. https://doi.org/10.1038/s41541-023-00733-8
Chicago
Ke Qiu, Xing Duan, Minzi Mao, Yao Song, Yufang Rao, Danni Cheng, Lan Feng, et al. 2023. “MRNA-LNP Vaccination-Based Immunotherapy Augments CD8+ T Cell Responses against HPV-Positive Oropharyngeal Cancer.” Npj Vaccines 8 (1): 1–15. doi:10.1038/s41541-023-00733-8.